bpc 157 tmj Intra-Articular Injection Of Peptides For Joint Pain Peptide Therapy Ocoee, FL |

In animal studies, AOD-9604 reduced body weight gain by over 50% in obese mice during a 19-day treatment period, and significantly increased fat oxidation all without affecting insulin sensitivity or glucose regulation.[1,3] A randomized controlled trial in humans found that participants taking 1 mg of AOD-9604 daily lost an average of 2.8 kg (~6 lbs) over 23 weeks, compared to 0.8 kg (~1.7 lbs) in the placebo group

The 2006 inflammopharmacology trial designation work introduced PL 14736 as the early-development name for the same compound, with reported activity on gastric vascular response

It is virtually painless

Weight of mice was followed during the experiment

This is where we connect the dots between the problem (a damaged, avascular disc) and the potential solution (a systemic healing peptide)